Thu 3 Dec 2009 | 5:19 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Peregrine Pharmaceuticals Inc

Peregrine Pharmaceuticals Inc (PPHM.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare . industry: Biotechnology ยท View PPHM on other exchanges
As of  2 Dec 2009
2.83USD
Price Change
+0.21
Percent Change
+8.02%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Fussey, Shelley 43 2005 Vice President - Intellectual Property
Shan, Joseph 36 2009 Vice President - Clinical & Regulatory Affairs
King, F. David 53 2005 Vice President - Business Development
King, Steven 45 2003 President, Chief Executive Officer, Director
Swartz, Eric 53 1999 Director
Johnson, Carlton 49 1999 Director
Pohl, David 72 2004 Director
Lytle, Paul 41 2002 Chief Financial Officer, Corporate Secretary